                               SEQUENCE LISTING

<110> KURA ONCOLOGY, INC.
 
<120> METHODS OF SELECTING CANCER PATIENTS FOR TREATMENT WITH 
      FARNESYLTRANSFERASE INHIBITORS

<130> 649875-228009

<140>
<141>

<150> 62/326,639
<151> 2016-04-22

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 535
<212> PRT
<213> Homo sapiens

<400> 1
Met Gly Ile Val Glu Pro Gly Cys Gly Asp Met Leu Thr Gly Thr Glu 
1               5                   10                  15      


Pro Met Pro Gly Ser Asp Glu Gly Arg Ala Pro Gly Ala Asp Pro Gln 
            20                  25                  30          


His Arg Tyr Phe Tyr Pro Glu Pro Gly Ala Gln Asp Ala Asp Glu Arg 
        35                  40                  45              


Arg Gly Gly Gly Ser Leu Gly Ser Pro Tyr Pro Gly Gly Ala Leu Val 
    50                  55                  60                  


Pro Ala Pro Pro Ser Arg Phe Leu Gly Ala Tyr Ala Tyr Pro Pro Arg 
65                  70                  75                  80  


Pro Gln Ala Ala Gly Phe Pro Gly Ala Gly Glu Ser Phe Pro Pro Pro 
                85                  90                  95      


Ala Asp Ala Glu Gly Tyr Gln Pro Gly Glu Gly Tyr Ala Ala Pro Asp 
            100                 105                 110         


Pro Arg Ala Gly Leu Tyr Pro Gly Pro Arg Glu Asp Tyr Ala Leu Pro 
        115                 120                 125             


Ala Gly Leu Glu Val Ser Gly Lys Leu Arg Val Ala Leu Asn Asn His 
    130                 135                 140                 


Leu Leu Trp Ser Lys Phe Asn Gln His Gln Thr Glu Met Ile Ile Thr 
145                 150                 155                 160 


Lys Gln Gly Arg Arg Met Phe Pro Phe Leu Ser Phe Thr Val Ala Gly 
                165                 170                 175     


Leu Glu Pro Thr Ser His Tyr Arg Met Phe Val Asp Val Val Leu Val 
            180                 185                 190         


Asp Gln His His Trp Arg Tyr Gln Ser Gly Lys Trp Val Gln Cys Gly 
        195                 200                 205             


Lys Ala Glu Gly Ser Met Pro Gly Asn Arg Leu Tyr Val His Pro Asp 
    210                 215                 220                 


Ser Pro Asn Thr Gly Ala His Trp Met Arg Gln Glu Val Ser Phe Gly 
225                 230                 235                 240 


Lys Leu Lys Leu Thr Asn Asn Lys Gly Ala Ser Asn Asn Val Thr Gln 
                245                 250                 255     


Met Ile Val Leu Gln Ser Leu His Lys Tyr Gln Pro Arg Leu His Ile 
            260                 265                 270         


Val Glu Val Asn Asp Gly Glu Pro Glu Ala Ala Cys Asn Ala Ser Asn 
        275                 280                 285             


Thr His Ile Phe Thr Phe Gln Glu Thr Gln Phe Ile Ala Val Thr Ala 
    290                 295                 300                 


Tyr Gln Asn Ala Glu Ile Thr Gln Leu Lys Ile Asp Asn Asn Pro Phe 
305                 310                 315                 320 


Ala Lys Gly Phe Arg Glu Asn Phe Glu Ser Met Tyr Thr Ser Val Asp 
                325                 330                 335     


Thr Ser Ile Pro Ser Pro Pro Gly Pro Asn Cys Gln Phe Leu Gly Gly 
            340                 345                 350         


Asp His Tyr Ser Pro Leu Leu Pro Asn Gln Tyr Pro Val Pro Ser Arg 
        355                 360                 365             


Phe Tyr Pro Asp Leu Pro Gly Gln Ala Lys Asp Val Val Pro Gln Ala 
    370                 375                 380                 


Tyr Trp Leu Gly Ala Pro Arg Asp His Ser Tyr Glu Ala Glu Phe Arg 
385                 390                 395                 400 


Ala Val Ser Met Lys Pro Ala Phe Leu Pro Ser Ala Pro Gly Pro Thr 
                405                 410                 415     


Met Ser Tyr Tyr Arg Gly Gln Glu Val Leu Ala Pro Gly Ala Gly Trp 
            420                 425                 430         


Pro Val Ala Pro Gln Tyr Pro Pro Lys Met Gly Pro Ala Ser Trp Phe 
        435                 440                 445             


Arg Pro Met Arg Thr Leu Pro Met Glu Pro Gly Pro Gly Gly Ser Glu 
    450                 455                 460                 


Gly Arg Gly Pro Glu Asp Gln Gly Pro Pro Leu Val Trp Thr Glu Ile 
465                 470                 475                 480 


Ala Pro Ile Arg Pro Glu Ser Ser Asp Ser Gly Leu Gly Glu Gly Asp 
                485                 490                 495     


Ser Lys Arg Arg Arg Val Ser Pro Tyr Pro Ser Ser Gly Asp Ser Ser 
            500                 505                 510         


Ser Pro Ala Gly Ala Pro Ser Pro Phe Asp Lys Glu Ala Glu Gly Gln 
        515                 520                 525             


Phe Tyr Asn Tyr Phe Pro Asn 
    530                 535 


<210> 2
<211> 1608
<212> DNA
<213> Homo sapiens

<400> 2
atgggcatcg tggagccggg ttgcggagac atgctgacgg gcaccgagcc gatgccgggg       60

agcgacgagg gccgggcgcc tggcgccgac ccgcagcacc gctacttcta cccggagccg      120

ggcgcgcagg acgcggacga gcgtcgcggg ggcggcagcc tggggtctcc ctacccgggg      180

ggcgccttgg tgcccgcccc gccgagccgc ttccttggag cctacgccta cccgccgcga      240

ccccaggcgg ccggcttccc cggcgcgggc gagtccttcc cgccgcccgc ggacgccgag      300

ggctaccagc cgggcgaggg ctacgccgcc ccggacccgc gcgccgggct ctacccgggg      360

ccgcgtgagg actacgcgct acccgcggga ctggaggtgt cggggaaact gagggtcgcg      420

ctcaacaacc acctgttgtg gtccaagttt aatcagcacc agacagagat gatcatcacc      480

aagcagggac ggcggatgtt cccattcctg tcatttactg tggccgggct ggagcccacc      540

agccactaca ggatgtttgt ggacgtggtc ttggtggacc agcaccactg gcggtaccag      600

agcggcaagt gggtgcagtg tggaaaggcc gagggcagca tgccaggaaa ccgcctgtac      660

gtccacccgg actcccccaa cacaggagcg cactggatgc gccaggaagt ttcatttggg      720

aaactaaagc tcacaaacaa caagggggcg tccaacaatg tgacccagat gattgtgctc      780

cagtccctcc ataagtacca gccccggctg catatcgttg aggtgaacga cggagagcca      840

gaggcagcct gcaacgcttc caacacgcat atctttactt tccaagaaac ccagttcatt      900

gccgtgactg cctaccagaa tgccgagatt actcagctga aaattgataa taaccccttt      960

gccaaaggat tccgggagaa ctttgagtcc atgtacacat ctgttgacac cagcatcccc     1020

tccccgcctg gacccaactg tcaattcctt gggggagatc actactctcc tctcctaccc     1080

aaccagtatc ctgttcccag ccgcttctac cccgaccttc ctggccaggc gaaggatgtg     1140

gttccccagg cttactggct gggggccccc cgggaccaca gctatgaggc tgagtttcga     1200

gcagtcagca tgaagcctgc attcttgccc tctgcccctg ggcccaccat gtcctactac     1260

cgaggccagg aggtcctggc acctggagct ggctggcctg tggcacccca gtaccctccc     1320

aagatgggcc cggccagctg gttccgccct atgcggactc tgcccatgga acccggccct     1380

ggaggctcag agggacgggg accagaggac cagggtcccc ccttggtgtg gactgagatt     1440

gcccccatcc ggccggaatc cagtgattca ggactgggcg aaggagactc taagaggagg     1500

cgcgtgtccc cctatccttc cagtggtgac agctcctccc ctgctggggc cccttctcct     1560

tttgataagg aagctgaagg acagttttat aactattttc ccaactga                  1608


